Solana Company (HSDT) reported second-quarter 2026 revenue of $2.5 million and a net loss of $30.3 million, or $0.38 per basic and diluted common share. Revenue included $2.5 million of staking revenue and $14,000 of other revenue.
The company said it completed the divestiture of its legacy PoNS medical device business and built its first institutional validator cluster in Tokyo.
- Total revenue was $2.526 million, compared with $43,000 in the prior-year quarter.
- Gross profit was $2.449 million, with a gross margin of approximately 97%.
- Net operating expenses were $35.122 million, including $11.116 million in general and administrative expenses.
- The company earned 31,200 SOL in staking rewards during the quarter.
- At June 30, 2026, total assets were $176.1 million, including $3.6 million in cash and cash equivalents.
- Solana Company completed a registered direct offering that generated net proceeds of $7.9 million and repurchased approximately $2.3 million of shares during the quarter.
